Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells

Clinical and Experimental Allergy

Volumn 40, Issue 8, 2010, Pages 1214-1221

  Muller T ^a   Durk T ^a   Blumenthal, B ^a   Herouy, Y ^a   Sorichter, S ^a   Grimm, M ^a   Panther, E ^a   Cicko, S ^a   Norgauer, J ^b   Idzko, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

dendritic cells; FoxP3; IL 10; iloprost; Tregs

Indexed keywords

CD45RA ANTIGEN; CYCLIC AMP; ILOPROST; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; PROSTANOID RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS; CELL SEPARATION; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; ILOPROST; LYMPHOCYTE ACTIVATION; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 77954372269     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03558.x     Document Type: Article

References (38)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
2. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev 2003 3 : 984 93.
3. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science(New York, NY) 2000 290 : 92 7.
4. Ueno H, Klechevsky E, Morita R et al. Dendritic cell subsets in health and disease. Immunol Rev 2007 219 : 118 42.
5. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001 13 : 114 9.
6. Panther E, Idzko M, Corinti S et al. The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 2002 169 : 4129 35.
7. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000 18 : 593 620.
8. Idzko M, Panther E, Corinti S et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 2002 16 : 625 7.
9. Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukotrienes Essent Fatty Acids 2003 69 : 157 62.
10. Park GY, Christman JW. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol 2006 290 : L797 805.
11. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004 18 : 790 804.
12. Helliwell RJ, Adams LF, Mitchell MD. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukotrienes Essent Fatty Acids 2004 70 : 101 13.
13. Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs 2004 64 : 2417 32.
14. Gavett SH, Madison SL, Chulada PC et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest 1999 104 : 721 32.
15. Jaffar Z, Wan KS, Roberts K. A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J Immunol 2002 169 : 5997 6004.
16. Hammad H, Kool M, Soullie T et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007 204 : 357 67.
17. Kunikata T, Yamane H, Segi E et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 2005 6 : 524 31.
18. Pavord ID, Wong CS, Williams J, Tattersfield AE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1993 148 : 87 90.
19. Nagao K, Tanaka H, Komai M, Masuda T, Narumiya S, Nagai H. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 2003 29 : 314 20.
20. Takahashi Y, Tokuoka S, Masuda T et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol 2002 137 : 315 22.
21. Idzko M, Hammad H, van Nimwegen M et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 2007 117 : 464 72.
22. Zhou W, Hashimoto K, Goleniewska K et al. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol 2007 178 : 702 10.
23. Hung CH, Chu YT, Suen JL et al. Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues. Eur Respir J 2009 33 : 405 10.
24. Panther E, Corinti S, Idzko M et al. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003 101 : 3985 90.
25. Lo RK, Liu AM, Wise H, Wong YH. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling. Cell Signal 2008 20 : 2095 106.
26. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005 201 : 981 9.
27. Idzko M, Hammad H, van Nimwegen M et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006 116 : 2935 44.
28. Henry E, Desmet CJ, Garze V et al. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol 2008 181 : 7230 42.
29. Lau AW, Biester S, Cornall RJ, Forrester JV. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J Immunol 2008 180 : 3889 99.
30. Hammad H, Lambrecht BN, Pochard P et al. Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol 2002 169 : 1524 34.
31. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 2006 176 : 5153 9.
32. Yamashita N, Tashimo H, Matsuo Y et al. Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model. J Allergy Clin Immunol 2006 117 : 1040 6.
33. D'Ambrosio A, Colucci M, Pugliese O, Quintieri F, Boirivant M. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. J Leukocyte Biol 2008 84 : 661 8.
34. + regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 2009 21 : 269 82.
35. + regulatory T cells by mycophenolic acid-treated dendritic cells. J Leukocyte Biol 2008 84 : 1057 64.
36. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009 373 : 1905 17.
37. Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008 31 : 891 901.
38. Gessler T, Schmehl T, Hoeper MM et al. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. Eur Respir J 2001 17 : 14 9.